MedPath

Hair Benefit Study For The Test Products

Not Applicable
Completed
Registration Number
CTRI/2021/09/036928
Lead Sponsor
nilever Industries Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
207
Inclusion Criteria

1.Female and male subjects in the ratio of 2:1 in general good health.

2.Subjects in the age group 18-42 years (both the ages inclusive).

3.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.

4.Subjects willing to abide by and comply with the study protocol.

5.Subjects who have not participated in a similar investigation in the past three months.

6.Subjects who agree to refrain from using hair dye / hair colour /henna during the study period.

7.Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration

8.Subjects who agree not to change their regular regimen (including hair oils)

Exclusion Criteria

1.Subjects who have undergone hair growth treatment within 3 months before screening into the study.

2.Subjects having any active scalp disease which may interfere in the study ââ?¬â?? dermatologistââ?¬•s judgement.

3.Subjects (male) having androgenic alopecia, male pattern baldnessââ?¬• not be included in study.

4.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.

5.Subjects (females) who are pregnant or lactating

6.Subjects who have had hair transplant.

7.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.

8.Chronic illness which may influence the cutaneous state.

9.Subjects participating in other similar cosmetic or therapeutic trial within last three months

10.Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.

11.Subjects (males) who are having androgenic alopecia, male pattern baldness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath